Levemir® is a soluble long-acting basal insulin analogue.
The duration of action is up to 24 hours depending on dose providing an opportunity for once or twice daily administration.
In combination with oral antidiabetic agents it is recommended to initiate Levemir treatment with once daily administration at a dose of 10 U or 0.1-0.2 U/kg and titrate to target. When Levemir is used in a basal-bolus regimen, Levemir should be administered once or twice daily depending on patients’ needs. Dosage of Levemir should be adjusted individually.
fergus said:The implication is that it isn't necessarily a once-a-day regimen, but that the best coverage for an individual will depend upon a number of variables. The NovoNordisk man is certain that the great majority of his customers find a split dose much more effective. The same is true for Lantus I think. The once-a-day promise is something that the market has demanded, but the products at the moment aren't quite up to it yet. There is a new longer-acting variant of Levemir on trial at the moment.
fergus
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?